Wade M. Aubry, MD

Articles by Wade M. Aubry, MD

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

ByAnupam B. Jena, MD, PhD,Jacquelyn W. Chou, MPP, MPL,Lara Yoon, MPH,Wade M. Aubry, MD,Jan Berger, MD, MJ,Wayne Burton, MD,A. Mark Fendrick, MD,Donna M. Fick, RN, PhD,David Franklin, BA,Rebecca Killion, MA,Darius N. Lakdawalla, PhD,Peter J. Neumann, ScD,Kavita Patel, MD, MSHS,John Yee, MD, MPH,Brian Sakurada, PharmD,Kristina Yu-Isenberg, PhD, MPH, RPh

November 13th 2018

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.

The Social Value of Childhood Vaccination in the United States

ByTomas J. Philipson, PhD,Julia Thornton Snider, PhD,Ayman Chit, PhD,Sarah Green, BA,Philip Hosbach, BA,Taylor Tinkham Schwartz, MPH,Yanyu Wu, PhD,Wade M. Aubry, MD

December 5th 2016

Vaccination of children born in the United States in 2009 will save 1.2 million quality-adjusted life-years, generating $184 billion in social value net of vaccination costs.

Session 2: Discussant

ByWade M. Aubry, MD

August 12th 2013

Wade M. Aubry, MD, associate clinical professor, University of California, San Francisco, continues discussions saying that comparative effectiveness research (CER) and the evolution of evidence-based medicine can facilitate innovations under the Affordable Care Act (ACA), especially with the inclusion of value-based insurance design (VBID).